Free Trial

Camden National Co. (NASDAQ:CAC) Shares Sold by Signaturefd LLC

Camden National logo with Finance background

Signaturefd LLC decreased its stake in Camden National Co. (NASDAQ:CAC - Free Report) by 54.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 20,242 shares of the financial services provider's stock after selling 24,415 shares during the period. Signaturefd LLC owned approximately 0.14% of Camden National worth $865,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the stock. Nisa Investment Advisors LLC boosted its holdings in Camden National by 18,500.0% in the fourth quarter. Nisa Investment Advisors LLC now owns 1,860 shares of the financial services provider's stock valued at $79,000 after purchasing an additional 1,850 shares during the last quarter. AlphaQuest LLC boosted its stake in shares of Camden National by 2,615.3% during the 4th quarter. AlphaQuest LLC now owns 4,263 shares of the financial services provider's stock valued at $182,000 after buying an additional 4,106 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in shares of Camden National during the fourth quarter worth approximately $210,000. Bryn Mawr Capital Management LLC bought a new stake in shares of Camden National in the fourth quarter worth $247,000. Finally, Foundations Investment Advisors LLC acquired a new stake in Camden National in the fourth quarter valued at $280,000. Institutional investors and hedge funds own 77.41% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on CAC shares. Raymond James reissued an "outperform" rating and issued a $53.00 target price (up previously from $50.00) on shares of Camden National in a research report on Wednesday, January 29th. StockNews.com initiated coverage on Camden National in a report on Monday. They issued a "hold" rating for the company. Finally, Keefe, Bruyette & Woods upped their price objective on Camden National from $48.00 to $50.00 and gave the company a "market perform" rating in a research note on Wednesday, January 29th.

Read Our Latest Report on CAC

Camden National Stock Performance

Shares of NASDAQ:CAC traded up $0.97 on Monday, reaching $42.01. 58,278 shares of the company's stock were exchanged, compared to its average volume of 58,903. The business's 50-day moving average is $43.54 and its two-hundred day moving average is $43.17. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.08. Camden National Co. has a fifty-two week low of $28.62 and a fifty-two week high of $50.07. The firm has a market capitalization of $708.50 million, a price-to-earnings ratio of 11.60 and a beta of 0.73.

Camden National (NASDAQ:CAC - Get Free Report) last released its quarterly earnings data on Tuesday, January 28th. The financial services provider reported $1.03 earnings per share for the quarter, topping the consensus estimate of $0.89 by $0.14. Camden National had a net margin of 18.02% and a return on equity of 10.38%. During the same quarter last year, the business earned $0.85 EPS. As a group, equities research analysts forecast that Camden National Co. will post 4.25 EPS for the current year.

Camden National Profile

(Free Report)

Camden National Corporation operates as the bank holding company for Camden National Bank that provides various commercial and consumer banking products and services for consumer, institutional, municipal, non-profit, and commercial customers in Maine, New Hampshire, and Massachusetts. The company accepts checking, savings, time, and brokered deposits, as well as deposits with the certificate of deposit account registry system.

Featured Stories

Institutional Ownership by Quarter for Camden National (NASDAQ:CAC)

Should You Invest $1,000 in Camden National Right Now?

Before you consider Camden National, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Camden National wasn't on the list.

While Camden National currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market
5 Stocks to BUY Now as Tariff Uncertainty Fades

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines